These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2183568)

  • 21. Protection of mice against lethal endotoxemia by lipid X is mediated through inhibition of neutrophil function.
    Lam C; Schütze E; Walzl H; Basalka E
    Circ Shock; 1987; 22(4):311-21. PubMed ID: 2820606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists.
    Lynn WA; Raetz CR; Qureshi N; Golenbock DT
    J Immunol; 1991 Nov; 147(9):3072-9. PubMed ID: 1717586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of kappa light chain synthesis in 70Z/3 B lymphoma cells by chemically defined lipid A precursors.
    Sibley CH; Terry A; Raetz CR
    J Biol Chem; 1988 Apr; 263(11):5098-103. PubMed ID: 3128535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-endotoxin activity of a novel synthetic lipid A analog.
    Kawata T; Bristol JR; Rose JR; Rossignol DP; Christ WJ; Asano O; Dubuc GR; Gavin WE; Hawkins LD; Kishi Y
    Prog Clin Biol Res; 1995; 392():499-509. PubMed ID: 8524958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition.
    Delude RL; Savedra R; Zhao H; Thieringer R; Yamamoto S; Fenton MJ; Golenbock DT
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9288-92. PubMed ID: 7568119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycolipid induced proliferation of lipopolysaccharide hyporesponsive C3H/HeJ splenocytes.
    Tomai MA; Johnson AG; Ribi E
    J Leukoc Biol; 1988 Jan; 43(1):11-7. PubMed ID: 3275732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Separation and characterization of toxic and nontoxic forms of lipid A.
    Takayama K; Qureshi N; Ribi E; Cantrell JL
    Rev Infect Dis; 1984; 6(4):439-43. PubMed ID: 6474003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of lipopolysaccharide-mediated activation of neutrophils with monosaccharide derivatives of lipid A.
    Lam C; Basalka E; Schütze E; Walzl H
    Prog Clin Biol Res; 1987; 236A():427-35. PubMed ID: 3615442
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of IL-1 by lipopolysaccharide (LPS) and its modulation by synthetic lipid A precursor Ia.
    Flad HD
    Lymphokine Res; 1990; 9(4):557-60. PubMed ID: 2090882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endotoxin and cancer chemo-prevention.
    Mastrangelo G; Fadda E; Cegolon L
    Cancer Epidemiol; 2013 Oct; 37(5):528-33. PubMed ID: 23692704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation and inhibition of Limulus amebocyte lysate coagulation by chemically defined substructures of lipid A.
    Proctor RA; Textor JA
    Infect Immun; 1985 Aug; 49(2):286-90. PubMed ID: 3894231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipopolysaccharide antagonists.
    Lynn WA; Golenbock DT
    Immunol Today; 1992 Jul; 13(7):271-6. PubMed ID: 1388655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo.
    Kovach NL; Yee E; Munford RS; Raetz CR; Harlan JM
    J Exp Med; 1990 Jul; 172(1):77-84. PubMed ID: 2193101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue metabolism during endotoxin shock after pretreatment with monophosphoryl lipid A.
    Klaus S; Staubach KH; Heringlake M; Gliemroth J; Schmucker P; Bahlmann L
    Cardiovasc Res; 2003 Jul; 59(1):105-12. PubMed ID: 12829181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diphosphoryl lipid A protects rats from lethal hyperoxia.
    Byran CL; Campbell GD; Lawrence RA; Jenkinson SG
    J Lab Clin Med; 1992 Sep; 120(3):444-52. PubMed ID: 1517689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial and anti-inflammatory agents that target endotoxin.
    Wyckoff TJ; Raetz CR; Jackman JE
    Trends Microbiol; 1998 Apr; 6(4):154-9. PubMed ID: 9587193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-glycosidic analogues of lipid A and lipid X: synthesis and biological activities.
    Vyplel H; Scholz D; Macher I; Schindlmaier K; Schütze E
    J Med Chem; 1991 Sep; 34(9):2759-67. PubMed ID: 1895296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioprotective properties of detoxified lipid A from Salmonella minnesota R595.
    Snyder SL; Walden TL; Patchen ML; MacVittie TJ; Fuchs P
    Radiat Res; 1986 Jul; 107(1):107-14. PubMed ID: 3488559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.